OUR PUBLICATIONS
2019
Eligibility for Local Therapies in Adolescents and Adults with Cutaneous Leishmaniasis from Southwestern Colombia: A Cross-Sectional Study.
Uribe-Restrepo AF, Prieto MD, Cossio A, Desai MM, Castro MDM.
Study. Am J Trop Med Hyg. 2019 Feb;100(2):306-310.
2019
The Candidate Blood- stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed Volunteers.
Steiner-Monard V, Kamaka K, Karoui O, Roethlisberger S, Audran R, Daubenberger C, Fayet-Mello A, Erdmann-Voisin A, Felger I, Geiger K, Govender L, Houard S, Huber E, Mayor C, Mkindi C, Portevin D, Rusch S, Schmidlin S, Tiendrebeogo RW, Theisen M, Thierry AC, Vallotton L, Corradin G, Leroy O, Abdulla S, Shekalaghe S, Genton B, Spertini F, Jongo SA.
Clin Infect Dis. 2019 Jan 18;68(3):466-474.
2018
Interventions to treat cutaneous leishmaniasis in children: A systematic review.
Uribe-Restrepo A, Cossio A, Desai MM, Dávalos D, Castro MDM.
PLoS Negl Trop Dis. 2018 Dec 14;12(12):e0006986.
2018
First field efficacy trial of the ChAd63 MVA ME- TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.
Tiono AB, Nébié I, Anagnostou N, Coulibaly AS, Bowyer G, Lam E, Bougouma EC, Ouedraogo A, Yaro JBB, Barry A, Roberts R, Rampling T, Bliss C, Hodgson S, Lawrie A, Ouedraogo A, Imoukhuede EB, Ewer KJ, Viebig NK, Diarra A, Leroy O, Bejon P, Hill AVS, Sirima SB.
PLoS One. 2018 Dec 12;13(12):e0208328.
2018
Workshop report: Experimental animal models for universal influenza vaccines.
D'Alessio F, Koopman G, Houard S, Remarque EJ, Stockhofe N, Engelhardt OG.
Vaccine. 2018 Nov 12;36(46):6895-6901.
2018
An international qualitative study exploring patients' experiences of cutaneous leishmaniasis: study set-up and protocol.
Erber AC, Arana B, Bennis I, Ben Salah A, Boukthir A, Castro Noriega MDM, Cissé M, Cota GF, Handjani F, Kebede MG, Lang T, López Carvajal L, Marsh K, Martinez Medina D, Plugge E, Olliaro P.
BMJ Open. 2018 Jun 15;8(6):e021372
2018
Recommendations of the VAC2VAC workshop on the design of multi-centre validation studies.
Halder M, Depraetere H, Delannois F, Akkermans A, Behr-Gross ME, Bruysters M, Dierick JF, Jungbäck C, Kross I, Metz B, Pennings J, Rigsby P, Riou P, Balks E, Dobly A, Leroy O, Stirling C.
Biologicals. 2018 Mar;52:78-82.
2018
Innovation Partnership for a Roadmap on Vaccines in Europe (IPROVE): A vision for the vaccines of tomorrow.
Medaglini D, De Azero MR, Leroy O, Bietrix F, Denoel P.
Vaccine. 2018 Feb 21;36(9):1136-1145.
2017
Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial.
Mensah VA, Roetynck S, Kanteh EK, Bowyer G, Ndaw A, Oko F, Bliss CM, Jagne YJ, Cortese R, Nicosia A, Roberts R, D'Alessio F, Leroy O, Faye B, Kampmann B, Cisse B, Bojang K, Gerry S, Viebig NK, Lawrie AM, Clarke E, Imoukhuede EB, Ewer KJ, Hill AVS, Afolabi MO.
Front Immunol. 2017 Nov 20;8:1551.
2017
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions.
Payne RO, Silk SE, Elias SC, Miura K, Diouf A, Galaway F, de Graaf H, Brendish NJ, Poulton ID, Griffiths OJ, Edwards NJ, Jin J, Labbé GM, Alanine DG, Siani L, Di Marco S, Roberts R, Green N, Berrie E, Ishizuka AS, Nielsen CM, Bardelli M, Partey FD, Ofori MF, Barfod L, Wambua J, Murungi LM, Osier FH, Biswas S, McCarthy JS, Minassian AM, Ashfield R, Viebig NK, Nugent FL, Douglas AD, Vekemans J, Wright GJ, Faust SN, Hill AV, Long CA, Lawrie AM, Draper SJ.
JCI Insight. 2017 Nov 2;2(21):e96381.